<DOC>
	<DOC>NCT02930434</DOC>
	<brief_summary>The purpose of this study is to evaluate vitamin D (VD) deficiency in the population of Chilean Antarctica and evaluate the efficacy and safety of VD supplementation to decrease VD deficiency and favorably influence biomarkers for bone, cardiovascular, and immune health risk in the inhabitants of Chilean Antarctica.</brief_summary>
	<brief_title>Effects of Antarctic Environment on Vitamin D Status and Health Risk Biomarkers of Its Inhabitants</brief_title>
	<detailed_description>The present study consists of an initial cross-sectional evaluation of VD status and specific health biomarkers in inhabitants of Chilean Antarctica, followed by a randomized controlled trial evaluating two acceptable approaches of vitamin D supplementation (cholecalciferol 600 IU daily vs. 25000 IU weekly) in Antarctic inhabitants.</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>population of all ages living in the Chilean Antarctic territory during at least 3 months. acute or chronic renal disease hyper or hypocalcemia osteomalacia or Paget's disease of bone use of VD supplements or fish oil supplements in the past month in doses higher than 400 IU daily treatment for known VD deficiency in the last 6 months UV phototherapy in the past month.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>Antarctica</keyword>
	<keyword>Chile</keyword>
	<keyword>cathelicidin</keyword>
	<keyword>bone metabolism</keyword>
	<keyword>cardiovascular risk</keyword>
</DOC>